Should I buy or sell Dr. Martens stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DOCS shares. View DOCS analyst ratings or view top-rated stocks .

What is Dr. Martens' stock price target for 2024?

2 Wall Street research analysts have issued 1 year target prices for Dr. Martens' shares. Their DOCS share price targets range from GBX 175 to GBX 180. On average, they expect the company's stock price to reach GBX 177.50 in the next twelve months. This suggests a possible upside of 161.2% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts .

How have DOCS shares performed in 2024?

Dr. Martens' stock was trading at GBX 88.60 at the start of the year. Since then, DOCS shares have decreased by 23.3% and is now trading at GBX 67.95. View the best growth stocks for 2024 here .

How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens?

Dr. Martens announced a dividend on Saturday, November 30th. Shareholders of record on Thursday, January 4th will be given a dividend of GBX 1.56 per share on Friday, February 2nd. This represents a yield of 1.36%. The ex-dividend date is Thursday, January 4th. The official announcement can be viewed at this link . Read our dividend analysis for DOCS .

Is Dr. Martens a good dividend stock?

Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 6.58%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for DOCS .

How do I buy shares of Dr. Martens?

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:DOCS

Dr. Martens (DOCS) Share Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free DOCS Stock Alerts

GBX 67.75

-2.10 (-3.00%)

(As of 03:21 PM ET)

Compare

Today's Range: 65.65
▼
71.65
50-Day Range: 67
▼
97.80
52-Week Range: 62
▼
174.70

Volume: 2.98 million shs
Average Volume: 1.58 million shs
Market Capitalization: £651.69 million

P/E Ratio: 677.54
Dividend Yield: 8.86%
Price Target: GBX 177.50

Stock Analysis Analyst Forecasts Chart Competitors Dividend Headlines Insider Trades

Get Dr. Martens alerts:

Dr. Martens MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 161.2% Upside
GBX 177.50 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.13
Based on 17 Articles This Week
Insider Trading: Acquiring Shares
£44,906 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.08 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Dr. Martens has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Dr. Martens has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for DOCS.

1.7

Dividend Strength

Dividend Leadership
Dr. Martens is a leading dividend payer. It pays a dividend yield of 6.58%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Dr. Martens does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Dr. Martens is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DOCS.

1.7

News and Social Media Coverage

News Sentiment
Dr. Martens has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.34 average news sentiment score of Consumer Cyclical companies.
News Coverage This Week
MarketBeat has tracked 17 news articles for Dr. Martens this week, compared to 2 articles on an average week.
Search Interest
Only 6 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Dr. Martens to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £449.06 in company stock and sold GBX 0 in company stock.
Percentage Held by Insiders
Only 4.12% of the stock of Dr. Martens is held by insiders.
Percentage Held by Institutions
73.65% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Dr. Martens is 679.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 135.64.
Price to Earnings Ratio vs. Sector
The P/E ratio of Dr. Martens is 679.50, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 353.06.
Price to Earnings Growth Ratio
Dr. Martens has a PEG Ratio of 2.70. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Dr. Martens has a P/B Ratio of 1.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Dr. Martens Stock (LON:DOCS)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

DOCS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DOCS Stock News Headlines

April 13, 2024 | insidertrades.com

Dr. Martens plc (LON:DOCS) Insider Jon Mortimore Acquires 159 Shares

April 18, 2024 | msn.com

Save up to 75% on Dr. Martens at Nordstrom Rack’s Flash sale this week only

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 17, 2024 | msn.com

Gen Z favorite Dr. Martens is struggling as its CEO steps down—and it might be because their shoes last too long

April 17, 2024 | theguardian.com

Dr Martens investors should be kicking themselves

April 16, 2024 | msn.com

Dr. Martens’ profit warning highlights U.S. consumer-confidence challenge

April 16, 2024 | finance.yahoo.com

Dr. Martens shares plunge to record low after weak US revenue outlook

April 16, 2024 | msn.com

Bootmaker Dr Martens names new CEO, flags tough year on weak demand

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 16, 2024 | msn.com

'No blister' Dr Martens boots in six colours that are a 'lifelong love' just £80 in sale

April 16, 2024 | markets.businessinsider.com

Dr. Martens Sees Annual Result In Line With Guidance; Says 2025 Outlook Challenging

April 16, 2024 | finance.yahoo.com

Dr. Martens Shares Tumble as Bootmaker Warns of Tough Year

April 16, 2024 | uk.finance.yahoo.com

Dr Martens shares dive to record low after profit warning and chief’s exit

April 16, 2024 | finance.yahoo.com

Dr. Martens Stock Plunges on Profit Warning, CEO Exit

April 16, 2024 | americanbankingnews.com

Dr. Martens (LON:DOCS) Sets New 52-Week Low at $65.50

April 14, 2024 | yahoo.com

Gwen Stefani Wears Sparkling Dr. Martens and Reunites With No Doubt at Coachella

April 14, 2024 | finance.yahoo.com

Under The Bonnet, Dr. Martens' (LON:DOCS) Returns Look Impressive

April 10, 2024 | msn.com

Olivia Rodrigo Casts Her Vote for 2024's It-Sneaker

April 10, 2024 | msn.com

The Olivia Rodrigo Guide to Girl-Power Menswear

April 9, 2024 | msn.com

Here’s Why More Shoe Brands Like Dr. Martens and New Balance Are Opting for Resale Programs

April 9, 2024 | axios.com

Multi-brand buyer fits Dr. Martens best

April 8, 2024 | msn.com

Olivia Rodrigo and Conan Gray Coordinate in Dr. Martens Shoes While Out in NYC

April 5, 2024 | msn.com

These TikTok-Famous Dr. Martens Mary Jane Shoes Easily Add Some Cool-Girl Edge to Your Feminine Spring Style - And They're 40% Off Today

April 4, 2024 | msn.com

The 7 Very Best Dr. Martens to Buy, As Told By Serial Docs Wearers

April 3, 2024 | thetimes.co.uk

Dr Martens feels heat from New York activist investor

April 2, 2024 | msn.com

Dr Marten's sale sees 'classic' £169 boots that are 'made to last' slashed to under £76

April 2, 2024 | msn.com

Will the stock market crash in 2024?

See More Headlines

Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/2 Dividend: 1/04/2024
Dividend Payable: 2/02/2024
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Consumer Cyclical
Industry: Footwear & Accessories
Sub-Industry: N/A
Current Symbol: LON:DOCS
CUSIP: N/A
CIK: N/A
Web: www.drmartensplc.com
Phone: 44 12 1415 7047
Fax: N/A
Employees: 2,591
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 177.50
High Stock Price Target: GBX 180
Low Stock Price Target: GBX 175
Potential Upside/Downside: +163.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX 0.10
Trailing P/E Ratio: 672.50
Forward P/E Ratio: 7.58
P/E Growth: 2.7
Net Income: £103.20 million
Net Margins: 10.56%
Pretax Margin: N/A
Return on Equity: 29.07%
Return on Assets: 10.31%

Debt

Debt-to-Equity Ratio: 143.48
Current Ratio: 2.44
Quick Ratio: 1.13

Sales & Book Value

Annual Sales: £977.50 million
Price / Sales: 0.66
Cash Flow: GBX 4.71 per share
Price / Cash Flow: 14.29
Book Value: GBX 37 per share
Price / Book: 1.82

Miscellaneous

Outstanding Shares: 961,850,000
Free Float: N/A
Market Cap: £646.84 million
Optionable: Not Optionable
Beta: -0.02

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Kenneth Wilson (Age 58)
CEO & Director
Comp: $773k
Mr. Jon William Mortimore (Age 57)
CFO & Director
Comp: $503k
Mr. Onyeije Ogueri Nwokorie (Age 54)
Chief Brand Officer
Comp: $67k
Mr. Geert Peeters (Age 58)
Chief Operating Officer
Mr. Ronald Garricks
Chief Information Officer
Ms. Meg Johnson
Chief Marketing Officer
Ms. Emily Clare Reichwald (Age 49)
Chief People & Sustainability Officer and Company Secretary
Mr. Sean O'Neill
Chief Digital Officer
Mr. Derek Chan
President of APAC
Mr. Adam M. Meek
Chief Product Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

DOCS Stock Analysis - Frequently Asked Questions

Should I buy or sell Dr. Martens stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DOCS shares.
View DOCS analyst ratings or view top-rated stocks.
What is Dr. Martens' stock price target for 2024?: 2 Wall Street research analysts have issued 1 year target prices for Dr. Martens' shares. Their DOCS share price targets range from GBX 175 to GBX 180. On average, they expect the company's stock price to reach GBX 177.50 in the next twelve months. This suggests a possible upside of 161.2% from the stock's current price.
View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts.
How have DOCS shares performed in 2024?: Dr. Martens' stock was trading at GBX 88.60 at the start of the year. Since then, DOCS shares have decreased by 23.3% and is now trading at GBX 67.95.
View the best growth stocks for 2024 here.
How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens?: Dr. Martens announced a dividend on Saturday, November 30th. Shareholders of record on Thursday, January 4th will be given a dividend of GBX 1.56 per share on Friday, February 2nd. This represents a yield of 1.36%. The ex-dividend date is Thursday, January 4th. The official announcement can be viewed at this link.
Read our dividend analysis for DOCS.

Is Dr. Martens a good dividend stock?: Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 6.58%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for DOCS.
How do I buy shares of Dr. Martens?: Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:DOCS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Dr. Martens (DOCS) Share Price, News & Analysis

Dr. Martens MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Dr. Martens Stock (LON:DOCS)

DOCS Stock Price History

DOCS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

DOCS Stock Analysis - Frequently Asked Questions

Overall MarketRank^™